Showing results (871-880 of 1,296) with videos related to
Sort By:
Pageof 130
Nature Reviews. Drug Discovery|July 19, 2014
The discovery of first-in-class drugs: origins and evolutionJörg Eder, Richard Sedrani, Christian WiesmannNature Reviews. Drug Discovery|April 7, 2016
Small molecules, big targets: drug discovery faces the protein-protein interaction challengeDuncan E Scott, Andrew R Bayly, Chris Abell, et al.Nature Reviews. Drug Discovery|October 14, 2017
WD40 repeat domain proteins: a novel target class?Matthieu Schapira, Mike Tyers, Maricel Torrent, et al.Nature Reviews. Drug Discovery|October 7, 2017
Tau-based therapies in neurodegeneration: opportunities and challengesChuanzhou Li, Jürgen GötzNature Reviews. Drug Discovery|July 15, 2017
Opportunities for therapeutic antibodies directed at G-protein-coupled receptorsCatherine J Hutchings, Markus Koglin, William C Olson, et al.Nature Reviews. Drug Discovery|March 5, 2016
Altering the course of schizophrenia: progress and perspectivesMark J Millan, Annie Andrieux, George Bartzokis, et al.Nature Reviews. Drug Discovery|December 19, 2015
The drug-target residence time model: a 10-year retrospectiveRobert A CopelandNature Reviews. Drug Discovery|September 2, 2014
Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disordersP Jeffrey Conn, Craig W Lindsley, Jens Meiler, et al.Nature Reviews. Drug Discovery|November 28, 2015
Moving from 'diagnose and treat' to 'predict and pre-empt' in neuropsychiatric disordersVaibhav A Narayan, Husseini K ManjiNature Reviews. Drug Discovery|November 28, 2015
Optogenetics enlightens neuroscience drug discoveryChenchen Song, Thomas KnöpfelPageof 130